HCA

HCA Healthcare
D

HCA

Arincen59/100B

If you had invested in HCA Healthcare ago, it would be worth $7,765 today, against $4,096 in SPY and $6,368 in QQQ.

ArincenArincen ScoreBeta

59/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability7.5

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation2

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength0

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2025; the price as of today.

HCA Healthcare key facts

Style
Value stock · 5.7/10Growth 4.1 · Value 5.7 · Dividend 1.5
Day range
502.26 – 505.96
52-week range
353.99 – 556.52
Market capitalization
104.96B USD
P/E
16.60
PEG ratio
1.75
EPS
30.27
Div Yield
0.62%
EPS growth forecast (FY2026)
+6.5%
Volume
12,259
Beta
1.11
ESG score
59.7/100Environment 59 · Social 56 · Governance 64
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Samuel N. Hazen
Employees
320K
IPO date
10 Mar 2011

HCA Healthcare earnings

Next earnings · Q4 FY2026
EPS estimate
8.15 USD
Revenue estimate
20.02B USD
Last quarter · Q3 FY2026
EPS7.22Beat +8.6%Revenue19.85BBeat +2.7%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20277.40——+2.51%20.58B——+3.66%
Q2 FY20277.54——-0.69%20.36B——+0.63%
Q1 FY20277.49——+4.75%19.91B——+4.17%
Q4 FY20268.15——+1.75%20.02B——+2.58%
Q3 FY20266.657.22+8.57%+3.74%19.33B19.85B+2.70%+3.59%
Q2 FY20267.567.59+0.40%+10.96%19.76B20.23B+2.40%+8.73%
Q1 FY20267.127.15+0.42%+10.85%19.09B19.11B+0.11%+4.30%
Q4 FY20257.468.01+7.37%+28.78%19.68B19.51B-0.87%+6.72%
Q3 FY20255.796.96+20.21%+38.37%18.60B19.16B+3.02%+9.57%
Q2 FY20256.296.84+8.74%+23.69%18.50B18.61B+0.57%+6.36%

Analysts' estimates for FY2026 over the last 7 days:EPS Revenue How the estimates moved

HCA Healthcare analyst forecast

12-month price target
463.12 USD
-7.83%

Analysts' 1-year price targets range from 369.00 to 579.00, with an average of 463.12.

Past year
1-year forecast
Strong sellStrong buy
Buy
21 ratings
Buy
14
Hold
6
Sell
1

12-month price target

Highest target579.00
Average target463.12
Lowest target369.00
Current price502.46

HCA Healthcare valuation

Price to earnings ratio (TTM)
16.60
Forward P/E (FY2026)
16.69
Price to sales (TTM)
1.33
EV / EBITDA (TTM)
9.84

Capital structure

Market capitalization
104.96B USD
+
Total debt
52.43B USD
−
Cash and short-term investments
908.00M USD
=
Enterprise value
156.48B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)14.38————
FY2027 (est.)16.0314.38———
FY2026 (est.)16.6916.03———
Now (TTM)16.6016.121.33—9.84
FY202516.3115.511.42-17.8710.05
FY202413.4810.851.10-31.068.70
FY202314.0712.361.13-41.569.01
FY202212.3413.181.16-25.188.20
FY202111.949.221.41-89.038.30

HCA Healthcare against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Tenet Healthcare, Encompass Health, DaVita, and The Ensign Group, the US Medical - Care Facilities companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median16.6
    7.619.7
  • Gross marginHighest in 5 years41.5%
    38.3%41.5%
    Against its peers: 3 of 5Peers' median 35.1%
  • Operating marginAbove its median15.8%
    14.8%16.5%
    Against its peers: 3 of 5Peers' median 15.4%
  • Net marginAt its median9.0%
    8.1%11.8%
    Against its peers: 2 of 5Peers' median 6.7%
  • Free cash flow marginHighest in 5 years10.2%
    6.9%10.2%
    Against its peers: 2 of 5Peers' median 8.5%
  • Revenue growthBelow its median7.1%
    2.5%14.0%
    Against its peers: 3 of 5Peers' median 8.5%
  • EPS growthAbove its median29.0%
    -9.5%93.6%
    Against its peers: 1 of 5Peers' median 1.3%
  • Debt to EBITDAAt its median3.22×
    2.58×3.29×
    Against its peers: 3 of 5Peers' median 4.32×
  • Current ratioLowest in 5 years0.83
    0.831.41
    Against its peers: 5 of 5Peers' median 1.36

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

HCA Healthcare growth and profitability

Revenue (TTM)
78.70B USD
Net income (TTM)
6.78B USD
Gross margin
21.69%
Operating margin
15.34%
Net margin
8.61%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202575.60B+7.08%6.78B+17.78%41.50%15.83%8.97%15.60B+12.28%
FY202470.60B+8.67%5.76B+9.88%40.62%14.94%8.16%13.90B+9.24%
FY202364.97B+7.86%5.24B-7.11%39.37%14.82%8.07%12.72B-4.28%
FY202260.23B+2.52%5.64B-18.88%38.48%15.03%9.37%13.29B-6.75%
FY202158.75B+14.01%6.96B+85.30%38.28%16.47%11.84%14.25B+46.40%

HCA Healthcare revenue breakdown

By product

FY2025
Managed Care And Other Insurers: 50.5%Managed Medicare: 18.4%Medicare: 15.4%Medicaid: 8.1%Managed Medicaid: 5.0%International: 2.5%50.5%Managed Care And Other Insurers18.4%Managed Medicare15.4%Medicare8.1%Medicaid5.0%Managed Medicaid2.5%International
SegmentRevenueShare of revenueChange on the year
Managed Care And Other Insurers36.97B50.5%+5.8%
Managed Medicare13.44B18.4%+12.1%
Medicare11.27B15.4%+4.6%
Medicaid5.91B8.1%+26.3%
Managed Medicaid3.69B5.0%-7.2%
International1.86B2.5%+10.8%

By region

FY2025
American Group: 36.5%Atlantic Group: 34.1%National Group: 29.4%36.5%American Group34.1%Atlantic Group29.4%National Group
RegionRevenueShare of revenueChange on the year
American Group26.45B36.5%+7.5%
Atlantic Group24.71B34.1%+6.6%
National Group21.28B29.4%+8.5%

How HCA Healthcare makes its money

Revenue75.60B 100.0%
Cost of revenue44.23B 58.5%
Gross profit31.37B 41.5%
Selling and administration8.00B 10.6%
Other operating expenses11.41B 15.1%
Operating income11.97B 15.8%
Tax2.05B 2.7%
Other expense3.13B 4.1%
Net income6.78B 9.0%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

HCA Healthcare dividends

Annual dividend
3.12 USD
Dividend yield (indicated)
0.62%
Payout ratio
12.69%
Years of dividend growth
6
Frequency
Quarterly
Next payment
0.78 USD
Next ex-dividend date
15 Dec 2026
Next payment date
29 Dec 2026

Dividends per share

Year202520242023202220212020201920182012
Dividends per share2.882.642.402.241.920.431.601.404.50

HCA Healthcare financial health

Cash and short-term investments
908.00M USD
Total debt
52.43B USD
Net cash
-51.52B USD
Free cash flow (TTM)
5.97B USD
Current ratio
0.82
Piotroski score
6 / 9
Altman Z-score
2.57

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20251.04B50.20B7.69B
FY20242.02B45.24B5.64B
FY2023935.00M41.86B4.69B
FY2022908.00M40.20B4.13B
FY20211.45B36.73B5.38B

HCA Healthcare ownership

Institutions
58.45%
Institutional holders
1,402 (-83)
Free float
66.82%

Who owns the shares

Institutions 58.5% Others 41.5%
As of 30 Jun 2026

Shares free to trade

Free float 139.59M shares ·66.8% Closely held 69.31M shares ·33.2%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 2026091.49M1.56M
Q3 2026000.007.77K
Q2 2026009.26K3.34K
Q1 2026012183.13M220.07M

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025230.71M239.50M-8.52%
FY2024258.60M261.81M-5.28%
FY2023272.40M276.41M-6.19%
FY2022290.35M294.67M-10.37%
FY2021323.32M328.75M-4.81%

Source: Financial Modeling PrepVerified against SEC filings

Related Instruments News

Title: HCA Healthcare

Sector: Healthcare
Industry: Medical - Care Facilities
HCA Healthcare Inc. is a holding company that specializes in providing healthcare services. Through its diversified affiliates, it owns and operates hospitals and related healthcare entities. It operates approximately 182 hospitals, which it fully owns. It also boasts ownership of roughly 125 freestanding surgery centers and over 21 freestanding endoscopy centers. Its hospitals focus on general and acute care, offering surgical services, intensive care, cardiac care, diagnostic services, emergency and outpatient services and much more.

Common questions about HCA Healthcare stock